Ep.80 – Exploring the Microbiome: Pertinent details from a phase 1 study exploring omadacycline in healthy guts

Episode Notes In this episode, DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard is joined by Dr. Kevin Garey, an adjunct professor at the University of Texas School of Public Health and senior author of the reviewed article. They walk us through the details of the microbiome effects oral omadacycline has versus oral vancomycin and what this might mean for the future of the treatment for C. difficile infections. The materials reviewed in today's episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38051631/ and https://pubmed.ncbi.nlm.nih.gov/22563022/ For more information about DASON, please visit: https://dason.medicine.duke.edu/

There are no comments yet.

Please log in to write the first comment.